IGF-1 LR3 Research Compound For Sale
Buy IGF-1 LR3 research compound: 1mg listed purchase quantities. Compare live prices across 9 listed vendors with real cost per mg, recorded COA availability and discount codes.
Buy IGF-1 LR3 research compound starting at $50.15/purchase from 9 listed vendors. Compare 1mg purchase quantity options by cost per mg, price per purchase, monthly cost, discount codes and recorded COA metadata (not independent verification).
How much does IGF-1 LR3 cost per month?
An illustrative IGF-1 LR3 cost model works out to about $76.00 per month: Flawless Compounds's listed 1 mg purchase quantity at $50.15 with code WPA, divided into 0.05 mg amounts daily. This quantity provides 20.0 nominal portions — about 2.9 weeks at the selected cadence, before preparation losses or stability limits — for roughly $17.55 per week or $76.00 per 4.33-week month. Vial count and milligrams per vial must be checked separately. This is illustrative arithmetic combining independently selected lifetime modal inputs, not a verified most-common joint protocol. The amount distribution includes 684 calculator runs; overall cadence comes from 155 separate lifetime frequency responses across amounts. Calculator inputs are not confirmed administration or recommendations.
Use the live cost-per-month card to change nominal purchase quantity, amount, cadence and vendor strategy. Recorded purity can be compared separately; it is not independent verification or a quality guarantee. Confirm package composition and checkout price with the vendor.
About IGF-1 LR3
Pre-clinical / research-onlyAlso known as: Long R3 IGF-1 · Long-R3-IGF-IIGF-1 LR3 (Long Arg³ IGF-1) is an insulin-like-growth-factor analog most often sourced in bodybuilding and recomposition research; it was originally made as a cell-culture reagent, not a human therapy. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.[1]
What to check before you buy IGF-1 LR3:
- A third-party COA showing ≥98% purity by HPLC plus mass-spec confirmation of the 83-amino-acid Long-R3 sequence — important for a larger, complex protein where the wrong variant or a misfolded product is a real risk.
- A COA dated within the last 6–12 months that matches the exact vial size and batch you are buying.
- Accurate vial fill: a 1mg label should assay close to 1mg. Under-filled or mislabeled vials are a common failure mode, and they throw off every reconstitution calculation.
IGF-1 LR3 is sold by major life-sciences suppliers (Sigma-Aldrich, Repligen, GroPep) as an animal-component-free supplement for CHO and hybridoma cell cultures used in biologics manufacturing.[3] No clinical-trial sponsor has ever pursued human therapeutic development; the molecule is explicitly not intended for human use, and the World Anti-Doping Agency lists IGF-1 LR3 as a prohibited substance.
Regulatory: Not FDA-approved for any human indication; sold strictly as a research / cell-culture reagent. Banned by the World Anti-Doping Agency under S2 (Peptide Hormones, Growth Factors).
IGF-1 LR3: Mechanisms, Half-Life & Research Data
A skimmable deep dive into how IGF-1 LR3 works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.
How it works
IGF-1 LR3 (Long Arg³ IGF-1) is an 83-amino-acid analog of human insulin-like growth factor 1, engineered by GroPep (now part of Repligen/Novozymes) in the early 1990s and sold today as a serum-free cell-culture supplement.[1][6] Two structural changes drive the unusual pharmacology: substituting glutamate-3 with arginine (the "Arg³" / "R³") sharply reduces binding to the six insulin-like-growth-factor-binding proteins (IGFBPs) that normally sequester roughly 99% of circulating IGF-1, and adding a 13-amino-acid N-terminal extension borrowed from porcine growth hormone preserves binding to the IGF-1 receptor while further blocking IGFBP-3 binding.[1][2] Net effect: IGF-1 LR3 is not buffered out of circulation by IGFBPs, so it shows substantially greater in-vivo bioactivity and a longer functional duration than native IGF-1 – Tomas and colleagues demonstrated this directly in a guinea-pig infusion model where Long-R3-IGF-I stimulated visceral organ growth more potently than native IGF-1 on a milligram-equivalent basis while suppressing endogenous IGF-I, IGF-II, and IGFBP levels.[4] Crucially, IGF-1 LR3 was designed as a cell-culture reagent for biologics manufacturing – not as a human therapy – and is sold by major life-sciences suppliers explicitly for that use.[6] No regulatory body anywhere has approved it for any human indication, and the World Anti-Doping Agency lists it as a prohibited substance under Section S2 of the WADA Prohibited List.[3]
Active research areas
- Cell-culture and biologics manufacturing (primary intended use)IGF-1 LR3 is sold by Sigma-Aldrich, Repligen, and other suppliers as an animal-component-free growth-factor supplement for CHO, hybridoma, and stem-cell cultures used in monoclonal-antibody and recombinant-protein manufacturing.[6] This is the only use for which the molecule was developed and the only one supported by a commercial product-development program.
- Pre-clinical anabolic and organ-growth modelsThe Tomas group's early-1990s rat work (Biochem J 1992, 1993) established that N-terminally modified IGF-I analogues including the Long-R3 variant are markedly more anabolic than native IGF-I in dexamethasone-treated and diabetic-rat models,[1][2] and the 1995 guinea-pig infusion study extended that finding to visceral organ growth (gut, liver, kidney) while showing suppression of endogenous IGF-I, IGF-II and IGFBP levels.[4] Together these papers are the data underpinning the modern bodybuilding-forum use case – no human therapeutic-development program has ever followed up on them.
- Theoretical use in muscle wasting and cachexiaNative IGF-1 (mecasermin) is FDA-approved for primary IGF-1 deficiency in children, and parallel rationale has motivated occasional academic interest in IGF-1 analogs for sarcopenia and cachexia – but no Phase 2 program of IGF-1 LR3 in muscle wasting has been published, and the IGFBP-bypass that makes the analog interesting for cell culture is the same feature that raises the safety concerns below.
- Anti-doping detection methodsBecause recombinant IGF-1 and Long-R3 IGF-1 analogues are banned by WADA under Section S2,[3] anti-doping laboratories have published characterisation work on detecting recombinant IGF-I misuse in athletes by serum mass spectrometry and IGF-I/IGFBP ratio screening – Holt and Sönksen reviewed the available methods and the analytical challenges in Anal Bioanal Chem 2013.[7]
- IGF-1R-mediated tumour-promotion biologyThe broader IGF-1 axis is well-characterised as a survival and proliferation signal in established epithelial cancers, and Pollak's 2008 Nature Reviews Cancer review summarises the case for IGF-1 signalling as a permissive factor for tumour growth – the safety frame within which any chronic IGF-1 LR3 use needs to be considered.[5]
Open questions & leading hypotheses (3)
- Hypothesis: Sub-cutaneous IGF-1 LR3 at bodybuilding-forum doses (20–100 µg/day for 4–6 week cycles) produces meaningful skeletal-muscle hypertrophy in healthy adults.Evidence: Pre-clinical infusion studies in animals show clear anabolic effects on multiple tissues including skeletal muscle.[1][2][4] Counter-evidence: no controlled human trial has measured lean-mass change on these protocols; community-reported gains are confounded by concurrent training, nutrition, and (very frequently) co-administered anabolic steroids and growth-hormone secretagogues; and the dose ranges in widespread community use are orders of magnitude below the per-kg doses used in the animal infusion work.
- Hypothesis: Chronic IGF-1 LR3 use carries a clinically meaningful tumour-promotion risk through systemic IGF-1R activation.Evidence: IGF-1R signalling is well-characterised as a survival and proliferation signal in established epithelial cancers,[5] and the IGFBP-bypass that defines IGF-1 LR3 maximises free-receptor exposure – the exact mechanism the broader IGF-1 epidemiology literature has flagged. Counter-evidence: there are no controlled human chronic-use cohorts of any size, so the absolute magnitude of risk in healthy adults at small subcutaneous doses is genuinely unknown; the risk inference is mechanistic and analogical rather than empirical.
- Hypothesis: Acute hypoglycaemia is the most common practical adverse effect of community-protocol IGF-1 LR3 dosing.Evidence: IGF-1 cross-reacts with the insulin receptor with low but non-trivial affinity, and bypassing IGFBP buffering produces a much steeper effective dose-response curve than native IGF-1; community reports consistently describe hypoglycaemic symptoms (sweating, tremor, brain fog) within an hour of post-workout dosing.[8][9] Counter-evidence: the magnitude and frequency have never been quantified in a controlled study.
What community users report
Anecdotal — not controlled-trial evidence
On r/Peptides, r/PeptideAdmin, and r/steroids, IGF-1 LR3 is run almost exclusively in bodybuilding/recomposition contexts at 20–100 µg subcutaneous per day for 4–6-week cycles, often peri-workout and frequently stacked with growth-hormone secretagogues or exogenous testosterone.[8][9] Users most commonly report acute hypoglycaemic symptoms within the first hour after dosing (sweating, tremor, mental fog – mitigated by pre-dose carbohydrate intake), modest visual fullness and pump amplification on training days, and a subset reports transient jaw, hand, or foot tenderness on longer cycles, consistent with the broader IGF-1 axis's effects on connective tissue. **These reports are anecdotal and have not been validated in controlled trials.** Given the WADA prohibition,[3] the IGF-1R-mediated tumour-promotion concern raised by the broader IGF-1 oncology literature,[5] and the absence of any human dose-response or chronic-use safety data, IGF-1 LR3 should be understood as a research-only reagent, not a deliberately developed human therapy.
Sources & references (9)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Tomas FM, Knowles SE, Owens PC, Chandler CS et al. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J 1992;282:91–97. · PMID: 1371669 link
- [2]Tomas FM, Knowles SE, Owens PC, Chandler CS et al. Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects. Biochem J 1993;291:781–786. · PMID: 7683875 link
- [3]World Anti-Doping Agency — 2024 Prohibited List, Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). link
- [4]Tomas FM et al. Long-R3-insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. J Endocrinol 1995;146:507–516. · PMID: 7561636 link
- [5]Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915–928. · PMID: 19029956 link
- [6]Repligen / GroPep technical data – LONG R³ IGF-I product information for serum-free cell-culture supplementation. link
- [7]Holt RIG, Sönksen PH et al. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection. Anal Bioanal Chem 2013;405:9837–9844. · PMID: 23934394 link
- [8]Community report – r/Peptides and r/PeptideAdmin IGF-1 LR3 protocol threads (subreddit), accessed May 2026. link
- [9]Community report – r/steroids IGF-1 LR3 bodybuilding-context discussions (subreddit), accessed May 2026. link
What IGF-1 LR3 Costs Right Now
WPA currently tracks IGF-1 LR3 from 9 distinct vendors. In-stock IGF-1 LR3 vials run from $50.15 to $89.99 — a 1.8x spread for the same compound. Flawless Compounds holds the lowest sticker price at $50.15. Normalized to milligrams, IGF-1 LR3 costs $50.15/mg to $89.99/mg on this page. The best per-milligram value is the listed 1 mg purchase quantity from Flawless Compounds.
IGF-1 LR3 is stocked in a single size: 1 mg listed quantity; vial count not recorded. Because vials of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.
Ranked by true cost per milligram, the IGF-1 LR3 listings WPA tracks are: Flawless Compounds — 1mg at $50.15 ($50.15/mg), COA purity 98.54%; Glow Aminos — 1mg at $50.15 ($50.15/mg), COA purity 98.54%; Swiss Chems — 1mg at $53.96 ($53.96/mg); LA Peptides — 1mg at $53.99 ($53.99/mg), COA purity 99.70%; Modified Aminos — 1mg at $53.99 ($53.99/mg), COA purity 99.00%.
IGF-1 LR3 COA Coverage Across Tracked Vendors
8 of the 9 tracked IGF-1 LR3 listings (89%) are marked as having COA availability in WPA's listing data; this marker is not independent verification. A purity value is recorded for 8 listings; purity alone does not establish identity or independent testing. The recorded purity values range from 98.54% to 99.90%. 8 listings record more IGF-1 LR3 in the vial than the label claims; check the vendor's report and batch before drawing conclusions. The latest COA date recorded in WPA's listing data is 9/26.
To assess a COA, inspect the actual report for the independent lab, test date, and a batch and vial size matching the IGF-1 LR3 offer. WPA's listing fields do not establish that a report was independently verified.
IGF-1 LR3 Calculator Input Observations
In lifetime IGF-1 LR3 calculator inputs, 50mcg is the most frequent entered amount (192 of 684 runs). Separately, Daily (7x/wk) is the most frequent overall cadence (47 of 155 lifetime frequency responses, across entered amounts). Among lifetime frequency responses with amounts within ±8% of 50mcg, Daily (7x/wk) is most frequent (20 of 39 responses). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. As nominal quantity arithmetic only, 1 mg of listed product divided by 0.05 mg gives roughly 20 portions before preparation losses. This does not establish vial count, stability after preparation, or cycle length.
IGF-1 LR3 Discount Codes
9 of the 9 tracked IGF-1 LR3 listings carry a WPA researcher discount code. The largest live discount is 15% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.
About IGF-1 LR3
IGF-1 LR3 (Long Arg³ IGF-1) is an insulin-like-growth-factor analog most often sourced in bodybuilding and recomposition research; it was originally made as a cell-culture reagent, not a human therapy. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.
IGF-1 LR3 is tracked under the Muscle Peptides category on WPA. Its reported half-life is ~20–30 hours. Calculator inputs do not establish why a cadence was selected or validate a protocol. Not FDA-approved for any human indication; sold strictly as a research / cell-culture reagent.
How to Read the IGF-1 LR3 Comparison
- Price per milligram — Every IGF-1 LR3 listing is normalized to $50.15/mg-style unit pricing, so a small cheap vial cannot hide a worse real cost than a larger one.
- COA metadata and purity — 8 IGF-1 LR3 listings are marked for COA availability, and 8 have a recorded purity value. These fields do not independently verify a report.
- Stock status — Live in-stock state for each IGF-1 LR3 listing, refreshed on a recurring basis.
Frequently Asked Questions: IGF-1 LR3
Is it legal and safe to buy IGF-1 LR3 for research?
In the US, IGF-1 LR3 is sold strictly as a research chemical — legal to buy for laboratory research but not approved for human use. It is a long-acting IGF-1 analog with no approved human use and a WADA ban in sport, sold strictly for laboratory research. The real variable isn't legality, it's quality: unverified suppliers can ship underdosed, impure, or mislabeled material. WPA records COA-related listing fields where supplied, but does not independently verify every report. Inspect the actual batch report and its laboratory, identity testing, and date before drawing conclusions. Right now that screen covers 9 IGF-1 LR3 listings from 9 vendors.
How do I verify a IGF-1 LR3 COA so I'm not getting an underdosed vial?
A Certificate of Analysis (COA) may report tests for a specific IGF-1 LR3 batch. Check that the report identifies the compound (actually IGF-1 LR3, not plain IGF-1, IGF-1 DES, or an underdosed vial), names the laboratory, describes the test method and result, and matches the offered batch and date. A recorded purity value or COA-availability flag in WPA's listing data is not independent verification. Open the vendor listing and inspect the actual report before drawing conclusions. For IGF-1 LR3 specifically, 8 of 9 tracked listings (89%) are marked as having COA availability in WPA's listing data; that marker is not independent verification. A purity value is separately recorded for 8 listings; purity alone does not establish identity or independent testing. The latest COA date recorded in the listing data is 9/26.
Which IGF-1 LR3 vendor should I pick?
There's no single "best" IGF-1 LR3 vendor — it depends on what you weigh most. WPA ranks tracked listings using recorded purity and date fields where available, visitor click activity, price, stock status, and discount data; this ranking is not independent verification of a report. IGF-1 LR3 is easy to confuse with IGF-1 DES and plain IGF-1, so a COA confirming the exact analog and the labeled amount matters more than usual. 9 vendors currently carry IGF-1 LR3, and Flawless Compounds holds the best true value at $50.15/mg on the 1 mg listed purchase quantity. Review the actual report and confirm its batch details before making a decision.
How much does IGF-1 LR3 cost — and how do I know I'm not overpaying?
Judge IGF-1 LR3 by true price per milligram, not the sticker price on one vial — a cheap small vial often costs more per mg than a larger one. It ships in vials priced per mg (often 1 mg), so compare $/mg across vials rather than the per-vial price. Tracked IGF-1 LR3 listings currently run $50.15/mg to $89.99/mg across 1mg listed purchase quantities (not necessarily single vials). WPA normalizes tracked listings to $/mg, and the live cost-per-month card estimates your spend at the most common dose. The one catch: the lowest $/mg sometimes means buying a bigger vial than your cycle needs.
How much IGF-1 LR3 do I need for one full cycle?
In lifetime IGF-1 LR3 calculator inputs, 50mcg is the most frequent entered amount (192 of 684 runs). Separately, Daily (7x/wk) is the most frequent overall cadence (47 of 155 lifetime frequency responses, across entered amounts). Among lifetime frequency responses with amounts within ±8% of 50mcg, Daily (7x/wk) is most frequent (20 of 39 responses). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. Dividing the listed 1 mg purchase quantity by 0.05 mg gives roughly 20 nominal portions before preparation losses; vial count and stability after preparation are separate questions. A cycle requires an independently chosen amount, cadence and time horizon; calculator observations do not supply those decisions. Compare nominal package quantities and model your own selections in the cost card.
Are discount codes available for IGF-1 LR3?
Participating IGF-1 LR3 vendors may offer WPA researcher discount codes. Codes can change, exclude sale items or carry order minimums. 9 of the 9 tracked IGF-1 LR3 listings carry a code right now, the largest worth 15% off. Each listing shows the recorded code and discounted price where available; confirm the actual package and checkout terms with the vendor.
Where can I compare IGF-1 LR3 prices and listing details?
This comparison shows 9 tracked listings for IGF-1 LR3 in the selected format. Compare purchase price, established nominal quantities, discount terms and recorded COA availability, purity and date fields. Those fields are not independent verification. Inspect actual batch reports and confirm package composition and checkout price on the vendor's site.